Orticumab (Anti-oxLDL)
Product Specifications
CAS Number
1314241-10-5
Synonyms
MLDL1278A
Target
LDL
Applications
Metabolism
Additionnal Information
Orticumab (MLDL1278A) is an antibody targeting oxidized or malondialdehyde-modified lipoprotein (LDL) that specifically inhibits oxidised low-density lipoproteins (oxLDL) . Orticumab is involved in the modulation of autoimmune responses against oxLDL and improves atherosclerosis in an animal model. MW: 145.5 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6432148-01 0.1 mL
POLDIP3 (Polymerase Delta-interacting Protein 3, SKAR, PDIP46) (MaxLight 750)
Sign In for Pricing
View Details MBS6432148-02 5x 0.1 mL
POLDIP3 (Polymerase Delta-interacting Protein 3, SKAR, PDIP46) (MaxLight 750)
Sign In for Pricing
View Details 
K1209902 1.0 µg DNA
LGALS3BP sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 25737064 1.0 µg DNA
KLC3 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details K2606-20 20 mL
Tartrate Resistant Acid Phosphatase (TRAP) staining Kit
Sign In for Pricing
View Details 